Skip to Main Content

Paper Details

Effects of itraconazole and rifampicin on the pharmacokinetics and safety of youkenafil, a novel phosphodiesterase type 5 inhibitor, in healthy Chinese subjects.
Eur J Pharm Sci
0
2022
CYP, CYP3A4/5, Itraconazole, M1, N-desethyl youkenafil, P450, Youkenafil, cytochrome, erectile dysfunction, human, human liver microsomes, itraconazole, phosphodiesterase type 5, recombinant, rifampicin, youkenafil
Author NameAffiliation
Li DingDepartment of Pharmaceutical Analysis, China Pharmaceutical University
Li DingDepartment of Pharmaceutical Analysis, China Pharmaceutical University
  • 1 - 2

Datasets

Release 1.2